Dr. Oren Fuerst Email & Phone Number

New York, Ny, Us

Fuerstech Innovations (AKA Strategic Models) creates and nurtures technologies that could improve the world while benefitting investors. We also provide strategic and financial advisory (to corporates and investors) on a broad range of areas, including Healthcare, Neurotech, Fintech, Agtech and Cleantech, e-commerce and Impact Investments.

Herzliya, Il

Created by Fuerstech Innovations. Developing Friendly and Intelligent Companion pet robots for the elderly population.

Created by Fuerstech Innovations. Technology platform to accompany Eating Disorders Fighters.

Herzliya, Israel, Il

Created by Fuerstech Innovations. Co-invented a Patented Personalized digital therapeutics (DTx) neuroscience company. Our patented stress measurement and reduction technology was shown in peer reviewed articles to affect diabetes and weight in a most profound way. www.eco-fusion.com

Innovation center and an investor Network. Initially, the first angel club in the US focusing exclusively on Israeli companies, in technology and life sciences. Later, activities expanded to Europe and China. Our center also assists investors and companies in scouting for exciting technologies, and educating about the future of technology. Created by Fuerstech Innovations.

Created by Fuerstech Innovations. Mobile, scalable Molecular Diagnostic platform. Co-inventor and co-founded Naor, a Disruptive Decentralized Saliva based Molecular Diagnostics Platform, initially focused around COVID-19. Obtained CE Mark and is being commercialized worldwide. Based on joint work of our superb team with the Israeli Technion, Columbia University and the Israeli Ministry of Defense (MAFAT).

Created by Fuerstech Innovations. Co-inventor and co-founder of an award winning, Patented Personalized Health information service. Based on user data, we derive a personalized health docket and updates.

Co-invented, founded and led as active Chairman the world changing, award winning Social Impact company. Innovative, first of its kind non surgical circumcision Device invented to fight the spread of HIV in Africa. First to obtain WHO, CE and FDA approval of such devices. Extensively used in Sub-Saharan Africa in more than 10 countries (with more than 1.5 million devices delivered). Multiple awards and patents (now opened sourced), as well as broad usage throughout Sub-Saharan Africa. Device was validated in more than 10 clinical studies with more than 100,000 participants (funded by the Gates Foundation, the Global Fund and U.S. AID), showing the device is safe and effective, and superior (safety wise) by a factor of 10 over traditional surgical circumcision, while saving significant costs. Created by Fuerstech Innovations.

Created by Fuerstech Innovations. Co-invented, co- founded and led as a CEO/ Chairman of the company from concept stage to become a public company, all within less than 2 years. A first of its kind FDA and CE cleared Mobile Health platform, initially focused around diabetes management. The patented Dario platform is combining a suite of cloud based services with multiple devices, the first one being a patented all-in-one smartphone connected glucose monitor. The platform was later broadened to is address mental health and musculoskeletal solutions.Led the company from inception and took it public (one of the first S-1s under the JOBS act) within less than two years from inception, while delivering high returns to its initial investors. Company trades on Nasdaq (NASDAQ: DRIO) and was awarded with multiple awards and patents for its innovativeness.

Using a combination of licensing and revived R&D activities, led the conversion (including co-inventing) of a one product dietary supplement company into a cross-listed biopharmaceutical company focused on oral immunotherapy, utilizing polyclonal antibody products targeting the human gut immune system and gut microbiome. The pipeline included drug candidates for HIV, Flu, and Nonalcoholic Fatty Liver Disease (NAFLD). Led the cross-listing process of the company into the U.S. The company trades in the U.S. under the ticker symbol NASDAQ: IMRN.

Extensive strategy, financial and R&D leadership roles on diverse areas including digital health, drug delivery methods, M&As and Spin-offs.

Invented and led as a CEO/Chairman the development of Hygiea- a pioneering Digital Health Platform. Created a patented technology originally designed as the backbone for national mass immunization campaigns, and later used for the digitization of clinical studies. Among the large scale deployments work: largest ever computerized clinical trial (funded by with the Gates foundation) and a U.S. emergency vaccination platform later acquired by Becton Dickinson ( NYSE: BDX). Created by Fuerstech Innovations.

Founding Director of the Technology Strategy and Valuation Executive Program and Faculty at Columbia Business School and Faculty at Yale University School of Management and Yale International Center for Finance, focusing on International and Technology Valuation and Management.

New York, Ny, Us

Worked in a special unit that focused on 1) assisting investors scouting for investment opportunities in Israel and 2) conducting financial analysis of mostly publicly traded companies.

Ph.D. And M.A., The Linkages Of Game Theory, Valuation, Public Offerings And Global Equity Markets

Bachelor'S Degree (Dual Cum Laude), Economics And Accounting

High School, Stem

Professor

Faculty